What is Castle Biosciences's PP&E (net)?

Castle Biosciences (CSTL) reported PP&E (net) of $100.93M in Q1 2026.

How has Castle Biosciences's PP&E (net) changed year-over-year?

Castle Biosciences's PP&E (net) increased by 82.1% year-over-year, from $55.42M to $100.93M.

What is the long-term trend for Castle Biosciences's PP&E (net)?

Over 5 years (2020 to 2025), Castle Biosciences's PP&E (net) has grown at a 68.8% compound annual growth rate (CAGR), from $7.1M to $97.44M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Castle Biosciences CSTL PP&E (Net)

PP&E (Net) at other companies

Labcorp HoldingsLH

$3.07B-0.8%

VeracyteVCYT

$22.65M+0.5%

Personalis, Inc.PSNL

$48.44M+0.9%

NeoGenomicsNEO

$83.66M-6.6%

Fulgent Genetics, Inc.FLGT

$116.34M+8.7%

Cogent Biosciences, Inc.COGT

$5.3M-17.9%

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's PP&E (net)?: Castle Biosciences (CSTL) reported PP&E (net) of $100.93M in Q1 2026.
How has Castle Biosciences's PP&E (net) changed year-over-year?: Castle Biosciences's PP&E (net) increased by 82.1% year-over-year, from $55.42M to $100.93M.
What is the long-term trend for Castle Biosciences's PP&E (net)?: Over 5 years (2020 to 2025), Castle Biosciences's PP&E (net) has grown at a 68.8% compound annual growth rate (CAGR), from $7.1M to $97.44M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.